Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 31

    1.

    Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India.

    Vidya M, Saravanan S, Uma S, Kumarasamy N, Sunil SS, Kantor R, Katzenstein D, Ramratnam B, Mayer KH, Suniti S, Balakrishnan P.

    Antivir Ther. 2009;14(7):1005-9.PMID: 19918105 [PubMed - in process]Related articles

    2.

    Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings.

    Kantor R, Diero L, Delong A, Kamle L, Muyonga S, Mambo F, Walumbe E, Emonyi W, Chan P, Carter EJ, Hogan J, Buziba N.

    Clin Infect Dis. 2009 Aug 1;49(3):454-62.PMID: 19569972 [PubMed - indexed for MEDLINE]Related articles

    3.

    High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings.

    Kumarasamy N, Madhavan V, Venkatesh KK, Saravanan S, Kantor R, Balakrishnan P, Devaleenal B, Poongulali S, Yepthomi T, Solomon S, Mayer KH, Benson C, Schooley R.

    Clin Infect Dis. 2009 Jul 15;49(2):306-9.PMID: 19522657 [PubMed - indexed for MEDLINE]Related articles

    4.

    Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house method.

    Saravanan S, Vidya M, Balakrishanan P, Kumarasamy N, Solomon SS, Solomon S, Kantor R, Katzenstein D, Ramratnam B, Mayer KH.

    J Virol Methods. 2009 Aug;159(2):211-6. Epub 2009 Apr 2.PMID: 19490976 [PubMed - indexed for MEDLINE]Related articles

    5.

    TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories.

    Land S, Cunningham P, Zhou J, Frost K, Katzenstein D, Kantor R, Chen YM, Oka S, DeLong A, Sayer D, Smith J, Dax EM, Law M; TAQAS Laboratory Network.

    J Virol Methods. 2009 Aug;159(2):185-93. Epub 2009 Mar 26.PMID: 19490972 [PubMed - indexed for MEDLINE]Related articles

    6.

    Envelope coreceptor tropism, drug resistance, and viral evolution among subtype C HIV-1-infected individuals receiving nonsuppressive antiretroviral therapy.

    Kassaye S, Johnston E, McColgan B, Kantor R, Zijenah L, Katzenstein D.

    J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):9-18.PMID: 19295330 [PubMed - indexed for MEDLINE]Related articles

    7.

    Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.

    Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, Heneine W, Kantor R, Jordan MR, Schapiro JM, Vandamme AM, Sandstrom P, Boucher CA, van de Vijver D, Rhee SY, Liu TF, Pillay D, Shafer RW.

    PLoS One. 2009;4(3):e4724. Epub 2009 Mar 6.PMID: 19266092 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy.

    Pillay V, Pillay C, Kantor R, Venter F, Levin L, Morris L.

    AIDS Res Hum Retroviruses. 2008 Nov;24(11):1449-54.PMID: 19000027 [PubMed - indexed for MEDLINE]Related articles

    9.

    Bayesian network analyses of resistance pathways against efavirenz and nevirapine.

    Deforche K, Camacho RJ, Grossman Z, Soares MA, Van Laethem K, Katzenstein DA, Harrigan PR, Kantor R, Shafer R, Vandamme AM; non-B Workgroup.

    AIDS. 2008 Oct 18;22(16):2107-15.PMID: 18832874 [PubMed - indexed for MEDLINE]Related articles

    10.

    HIV-2 diagnosis and quantification in high-risk patients.

    Chan PA, Wakeman SE, Flanigan T, Cu-Uvin S, Kojic E, Kantor R.

    AIDS Res Ther. 2008 Aug 14;5:18.PMID: 18700986 [PubMed]Related articlesFree article

    11.

    Drug resistance in plasma and breast milk after single-dose nevirapine in subtype C HIV type 1: population and clonal sequence analysis.

    Kassaye S, Lee E, Kantor R, Johnston E, Winters M, Zijenah L, Mateta P, Katzenstein D.

    AIDS Res Hum Retroviruses. 2007 Aug;23(8):1055-61.PMID: 17725424 [PubMed - indexed for MEDLINE]Related articles

    12.

    Impact of HIV-1 pol diversity on drug resistance and its clinical implications.

    Kantor R.

    Curr Opin Infect Dis. 2006 Dec;19(6):594-606. Review.PMID: 17075337 [PubMed - indexed for MEDLINE]Related articles

    13.

    HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes.

    Rhee SY, Kantor R, Katzenstein DA, Camacho R, Morris L, Sirivichayakul S, Jorgensen L, Brigido LF, Schapiro JM, Shafer RW; International Non Subtype B HIV-1 Working Group.

    AIDS. 2006 Mar 21;20(5):643-51.PMID: 16514293 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.

    Snoeck J, Kantor R, Shafer RW, Van Laethem K, Deforche K, Carvalho AP, Wynhoven B, Soares MA, Cane P, Clarke J, Pillay C, Sirivichayakul S, Ariyoshi K, Holguin A, Rudich H, Rodrigues R, Bouzas MB, Brun-Vézinet F, Reid C, Cahn P, Brigido LF, Grossman Z, Soriano V, Sugiura W, Phanuphak P, Morris L, Weber J, Pillay D, Tanuri A, Harrigan RP, Camacho R, Schapiro JM, Katzenstein D, Vandamme AM.

    Antimicrob Agents Chemother. 2006 Feb;50(2):694-701.PMID: 16436728 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The HIV-1 Non-subtype B Workgroup: an international collaboration for the collection and analysis of HIV-1 non-subtype B data.

    Kantor R, Shafer RW, Katzenstein D; HIV-1 Non-subtype B Workgroup.

    MedGenMed. 2005 Feb 23;7(1):71. No abstract available. PMID: 16369376 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine.

    Lee EJ, Kantor R, Zijenah L, Sheldon W, Emel L, Mateta P, Johnston E, Wells J, Shetty AK, Coovadia H, Maldonado Y, Jones SA, Mofenson LM, Contag CH, Bassett M, Katzenstein DA; HIVNET 023 Study Team.

    J Infect Dis. 2005 Oct 1;192(7):1260-4. Epub 2005 Aug 23.PMID: 16136470 [PubMed - indexed for MEDLINE]Related articles

    17.

    HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India.

    Balakrishnan P, Kumarasamy N, Kantor R, Solomon S, Vidya S, Mayer KH, Newstein M, Thyagarajan SP, Katzenstein D, Ramratnam B.

    AIDS Res Hum Retroviruses. 2005 Apr;21(4):301-5.PMID: 15943572 [PubMed - indexed for MEDLINE]Related articles

    18.

    Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration.

    Kantor R, Katzenstein DA, Efron B, Carvalho AP, Wynhoven B, Cane P, Clarke J, Sirivichayakul S, Soares MA, Snoeck J, Pillay C, Rudich H, Rodrigues R, Holguin A, Ariyoshi K, Bouzas MB, Cahn P, Sugiura W, Soriano V, Brigido LF, Grossman Z, Morris L, Vandamme AM, Tanuri A, Phanuphak P, Weber JN, Pillay D, Harrigan PR, Camacho R, Schapiro JM, Shafer RW.

    PLoS Med. 2005 Apr;2(4):e112. Epub 2005 Apr 26.PMID: 15839752 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The HIV-1 Non-subtype B Workgroup: An International Collaboration for the Collection and Analysis of HIV-1 Non-subtype B Data.

    Kantor R, Shafer RW, Katzenstein D; the HIV-1 Non-subtype B Workgroup*.

    J Int AIDS Soc. 2005 Feb 23;7(1):71.PMID: 19825127 [PubMed - as supplied by publisher]Free article

    20.

    K103N mutation in antiretroviral therapy-naive African patients infected with HIV type 1.

    Akinsete O, Hirigoyen D, Cartwright C, Schut R, Kantor R, Henry K.

    Clin Infect Dis. 2004 Aug 15;39(4):575-8. Epub 2004 Jul 30.PMID: 15356825 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...